Learn Before
Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations
Diabetes was considered a comorbidity during SARS-CoV-1. Similarly, having diabetes tripled the risk of hospitalization and quadrupled the risk of ICU admission during the Influenza A (H1N1) outbreak in 2009. During the 2012 outbreak of MERS-CoV, the mortality rate for patients with diabetes was a staggering 35%. Patients with diabetes who test positive for COVID-19 are more likely to experience severe disease.
0
1
Tags
SARS-CoV-2 (COVID-19)
Biomedical Sciences
Related
Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations
COVID-19 and diabetes: Knowledge in progress
The Link Between Diabetes and ACE2
Diabetes in COVID-19 Patients by Geographic Location
Diabetes Mellitus and a study of its Epidemiology in relation to COVID-19
The effect of hyperglycemia in relation ot COVID-19
Degree of Hyperglycemia on COVID-19 Mortality
Diabetes Medication on COVID-19 Mortality
COVID-19 and endocrine diseases. A statement from the European Society of Endocrinology
How Elevated Glucose Levels Favor SARS-CoV-2 Infection?